Stereoselective glucuronidation of 5-(4′-hydroxyphenyl)-5- phenylhydantoin by human UDP-glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: Effects of UGT-UGT interactions

Drug Metabolism and Disposition

Volumn 35, Issue 9, 2007, Pages 1679-1686

  Nakajima, Miki ^a   Yamanaka, Hiroyuki ^a   Fujiwara, Ryoichi ^a   Katoh, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4' HYDROXYPHENYL) 5 PHENYLHYDANTOIN; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B15; ISOENZYME; PHENYTOIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CELL STRAIN HEK293; DRUG GLUCURONIDATION; DRUG METABOLISM; EMBRYO; HUMAN; HUMAN CELL; LIVER MICROSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEREOCHEMISTRY;

ALGORITHMS; ANIMALS; BLOTTING, WESTERN; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; KINETICS; MICROSOMES, LIVER; PHENYTOIN; SPODOPTERA; STEREOISOMERISM;

EID: 34548055967     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.015909     Document Type: Article

References (25)

1. Bajpai M, Roskos LK, Shen DD, and Levy RH (1996) Roles of cytochrome P4502C9 and cytochrome P4502C19 in the stereoselective metabolism of phenytoin to its major metabolites. Drug Metab Dispos 24:1401-1403.
2. Barbier O, Girard C, Breton R, Belanger A, and Hum DW (2000) N-Glycosylation and residue 96 are involved in the functional properties of UDP-glucuronosyltransferase enzymes. Biochemistry 39:11540- 11552.
3. Basu NK, Kovarova M, Garza A, Kubota S, Saha T, Mitra PS, Banerjee R, Rivera J, and Owens IS (2005) Phosphorylation of a UDP-glucuronosyltransferase regulates substrate specificity. Proc Natl Acad Sci U S A 102:6285-6290.
4. Bichlmaier I, Siiskonen A, Finel M, and Yli-Kauhaluoma J (2006) Stereochemical sensitivity of the human UDP-glucuronosyltransferases 2B7 and 2B17. J Med Chem 49:1818-1827.
5. Cornish-Bowden A (1995) Fundamentals of Enzyme Kinetics, rev ed, Portland Press, London.
6. Court MH, Duan SX, Guillemette C, Journault K, Krishnaswamy S, von Moltke LL, and Greenblatt DJ (2002) Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Dispos 30:1257-1265.
7. Fujiwara R, Nakajima M, Yamanaka H, Katoh M, and Yokoi T (2007a) Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities. Drug Metab Dispos, in press.
8. Fujiwara R, Nakajima M, Yamanaka H, Nakamura A, Katoh M, Ikushiro S, Sakaki T, and Yokoi T (2007b) Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos 35:747-757.
9. Ghosh SS, Sappal BS, Kalpana GV, Lee SW, Chowdhury JR, and Chowdhury NR (2001) Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. J Biol Chem 276:42108-42115.
10. Giancarlo GM, Venkatakrishnan K, Granda BW, von Moltke LL, and Greenblatt DJ (2001) Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur J Clin Pharmacol 57:31-36.
11. Houston JB and Kenworthy KE (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28:246-254.
12. Ieiri I, Goto W, Hirata K, Toshitani A, Imayama S, Ohyama Y, Yamada H, Ohtsubo K, and Higuchi S (1995) Effect of 5-(p-hydroxyphenyl)-5- phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic-gingival hyperplasia: in vivo and in vitro study. Eur J Clin Pharmacol 49:51-56.
13. Ieiri I, Hirata K, Higuchi S, Kojima K, Ikeda M, Yamada H, and Aoyama T (1992) Pharmacoepidemiological study on adverse reactions of antiepileptic drugs. Chem Pharm Bull 40:1280-1288.
14. Kim PM and Wells PM (1996) Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation. Mol Pharmacol 49:172-181.
15. Kurkela M, Garcia-Horsman JA, Luukkanen L, Morsky S, Taskinen J, Baumann M, Kostiainen R, Hirvonen J, and Finel M (2003) Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs): UGT1A9 is more resistant to detergent inhibition than the other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278:3536-3544.
16. Mackenzie PI, Walter Bock K, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-685.
17. Matern H, Matern S, and Gerok W (1982) Isolation and characterization of rat liver microsomal UDP-glucuronosyltransferase activity toward chenodeoxycholic acid and testosterone as a single form of enzyme. J Biol Chem 257:7422-7429.
18. Meech R and Mackenzie PI (1997) UDP-glucuronosyltransferase, the role of the amino terminus in dimerization. J Biol Chem 272:26913-26917.
19. Nakajima M, Sakata N, Ohashi N, Kume T, and Yokoi T (2002) Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4′-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes. Drug Metab Dispos 30:1250-1256.
20. Parman T, Chen G, and Wells PG (1998) Free radical intermediates of phenytoin and related teratogens. J Biol Chem 273:25079-25088.
21. Sten T, Qvisen S, Uutela P, Luukkanen L, Kostiainen R, and Finel M (2006) Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10. Drug Metab Dispos 34:1488-1494.
22. Tougou K, Gotou H, Ohno Y, and Nakamura A (2004) Stereoselective glucuronidation and hydroxylation of etodolac by UGT1A9 and CYP2C9 in man. Xenobiotica 34:449-461.
23. Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, and Miners JO (2004) Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32:413-423.
24. Yamanaka H, Nakajima M, Hara Y, Katoh M, Tachibana O, Yamashita J, and Yokoi T (2005) Urinary excretion of phenytoin metabolites, 5-(4′- hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases. Drug Metab Pharmacokinet 20:135-143.
25. Yasumori T, Chen LS, Li QH, Ueda M, Tsuzuki T, Goldstein JA, Kato R, and Yamazoe Y (1999) Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Biochem Pharmacol 57:1297-1303.